Medesis Pharma SA Defensive Interval Ratio
Medesis Pharma SA defensive interval ratio. Medesis Pharma SA (ALMDP) has a Defensive Interval Ratio of 0 days as of June 2024. Defensive assets of €4.54K (cash €-, short-term investments €-, receivables €4.54K) cover 0 days of daily cash needs of €10.44K/day. See Medesis Pharma SA (ALMDP) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Medesis Pharma SA (2018–2023)
Defensive interval ratio of Medesis Pharma SA from 2018 to 2023. This chart shows how Medesis Pharma SA's Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the ratio stands at 0 days, meaning defensive assets of €4.54K can fund 0 days of operations without new revenue. Check ALMDP asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Medesis Pharma SA Defensive Interval Ratio by Year (2018–2023)
Medesis Pharma SA defensive interval ratio by year from 2018 to 2023. The table below presents the year-by-year Defensive Interval Ratio for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Medesis Pharma SA asset portfolio.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 40 days | €439.20K | €11.10K/day | €- | €-28.50K | ▲ +7 days |
| 2022 | 32 days | €170.59K | €5.29K/day | €- | €- | ▼ -1168 days |
| 2021 | 1200 days | €5.66 Million | €4.71K/day | €2.89 Million | €2.70 Million | ▲ +1119 days |
| 2020 | 81 days | €441.34K | €5.44K/day | €65.45K | €- | ▼ -240 days |
| 2019 | 321 days | €458.00K | €1.43K/day | €75.00K | €- | ▲ +260 days |
| 2018 | 61 days | €95.00K | €1.55K/day | €95.00K | €- | — |